HomeCompareZIMV vs ORCC

ZIMV vs ORCC: Dividend Comparison 2026

ZIMV yields 10.53% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZIMV wins by $18.7K in total portfolio value
10 years
ZIMV
ZIMV
● Live price
10.53%
Share price
$18.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.1K
Annual income
$2,038.90
Full ZIMV calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ZIMV vs ORCC

📍 ZIMV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZIMVORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZIMV + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZIMV pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZIMV
Annual income on $10K today (after 15% tax)
$895.21/yr
After 10yr DRIP, annual income (after tax)
$1,733.07/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ZIMV beats the other by $1,732.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZIMV + ORCC for your $10,000?

ZIMV: 50%ORCC: 50%
100% ORCC50/50100% ZIMV
Portfolio after 10yr
$30.8K
Annual income
$1,019.97/yr
Blended yield
3.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ZIMV
Analyst Ratings
5
Hold
1
Sell
Consensus: Hold
Price Target
$13.00
-31.5% upside vs current
Range: $9.00 — $20.00
Altman Z
0.9
Piotroski
6/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZIMV buys
0
ORCC buys
0
No recent congressional trades found for ZIMV or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZIMVORCC
Forward yield10.53%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$40.1K$21.4K
Annual income after 10y$2,038.90$1.04
Total dividends collected$15.4K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$13.00$16.00

Year-by-year: ZIMV vs ORCC ($10,000, DRIP)

YearZIMV PortfolioZIMV Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$11,753$1,053.19$11,190$489.61+$563.00ZIMV
2$13,733$1,156.85$12,229$256.01+$1.5KZIMV
3$15,957$1,263.27$13,216$130.74+$2.7KZIMV
4$18,446$1,371.87$14,207$66.02+$4.2KZIMV
5$21,220$1,482.10$15,234$33.17+$6.0KZIMV
6$24,298$1,593.39$16,317$16.62+$8.0KZIMV
7$27,704$1,705.21$17,468$8.32+$10.2KZIMV
8$31,461$1,817.05$18,695$4.16+$12.8KZIMV
9$35,591$1,928.43$20,006$2.08+$15.6KZIMV
10$40,122$2,038.90$21,407$1.04+$18.7KZIMV

ZIMV vs ORCC: Complete Analysis 2026

ZIMVStock

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Full ZIMV Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ZIMV vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZIMV vs SCHDZIMV vs JEPIZIMV vs OZIMV vs KOZIMV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.